|
NKIRAS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.24049684255579E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.52059953307094E-10 |
| Normal-vs-Stage2 |
1.940480E-03 |
| Normal-vs-Stage3 |
1.5187999968802E-08 |
| Normal-vs-Stage4 |
1.11859999041286E-09 |
| Stage1-vs-Stage2 |
5.438400E-02 |
| Stage1-vs-Stage3 |
6.009000E-01 |
| Stage1-vs-Stage4 |
6.132400E-02 |
| Stage2-vs-Stage3 |
4.040400E-02 |
| Stage2-vs-Stage4 |
2.042000E-03 |
| Stage3-vs-Stage4 |
1.852210E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.64579477718507E-11 |
| Normal-vs-AfricanAmerican |
5.622200E-03 |
| Normal-vs-Asian |
8.95839999959236E-08 |
| Caucasian-vs-AfricanAmerican |
1.682170E-01 |
| Caucasian-vs-Asian |
6.411200E-01 |
| AfricanAmerican-vs-Asian |
1.099190E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.0051004473155E-10 |
| Normal-vs-Female |
1.13830000980641E-09 |
| Male-vs-Female |
1.162380E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.98199998027826E-09 |
| Normal-vs-Age(41-60Yrs) |
1.36040000375814E-08 |
| Normal-vs-Age(61-80Yrs) |
1.21819999976402E-07 |
| Normal-vs-Age(81-100Yrs) |
1.319320E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.055800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.254800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.163200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.890600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.949000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.968600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.968500E-02 |
| Classical-VS-Follicular |
1.877350E-01 |
| Classical-VS-Other |
9.043200E-01 |
| Classical-VS-Normal |
4.34190017273295E-10 |
| Tall-VS-Follicular |
4.675900E-03 |
| Tall-VS-Other |
2.490200E-01 |
| Tall-VS-Normal |
3.61170005014344E-09 |
| Follicular-VS-Other |
7.722400E-01 |
| Follicular-VS-Normal |
5.6104999999973E-05 |
| Other-VS-Normal |
3.741700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.21430000499245E-08 |
| Normal-vs-N1 |
1.26599952743334E-10 |
| N0-vs-N1 |
2.057800E-03 |
|
|
